Subgroups of Sjögren syndrome patients according to serological profiles

VK Bournia, PG Vlachoyiannopoulos - Journal of autoimmunity, 2012 - Elsevier
Sjögren Syndrome (SS) is a systemic, autoimmune disorder characterized by lymphocytic
infiltration of the exocrine glands. Different clinical associations have been described for each …

Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort

S Panopoulos, VK Bournia, G Konstantonis… - Autoimmunity …, 2018 - Elsevier
Objectives To determine predictors of morbidity and mortality in systemic sclerosis (SSc) in
a long-term follow-up of an inception cohort of early SSc patients. Methods We evaluated …

Therapeutic inhibition of tyrosine kinases in systemic sclerosis: a review of published experience on the first 108 patients treated with imatinib

VK Bournia, K Evangelou, PP Sfikakis - Seminars in arthritis and …, 2013 - Elsevier
OBJECTIVE: Experimental and clinical evidence suggest a therapeutic role for the tyrosine
kinase inhibitor imatinib in fibrosing conditions. We evaluated published data on the safety …

[HTML][HTML] Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis

VKK Bournia, KD Diamanti… - Arthritis research & …, 2010 - Springer
Introduction A subgroup of patients with primary Sjögren's Syndrome (SS) and positive
anticentromere antibodies (ACA) were recognized as having features intermediate between SS …

Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides

…, M Douskou, D Panagiotakos, V Bournia… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Myocardium and coronary arteries can occasionally be affected in patients with
systemic necrotizing vasculitides; however, such involvement has not been systematically …

Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases

…, K Fragiadaki, G Evangelatos, VK Bournia… - Annals of the …, 2022 - ard.bmj.com
Objective Τo report outcomes of breakthrough COVID-19 in comparison with COVID-19 in
unvaccinated patients with systemic rheumatic diseases (SRDs). Methods Patients with SRD …

All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019

VK Bournia, GE Fragoulis, P Mitrou, K Mathioudakis… - RMD open, 2021 - rmdopen.bmj.com
Objectives To compare current all-cause mortality rates in rheumatoid arthritis (RA),
ankylosing spondylitis (AS), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE) and …

Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic

…, G Evangelatos, A Arida, VK Bournia… - Annals of the …, 2021 - ard.bmj.com
We read with great interest the preliminary German Society of Rheumatology recommendations
for the management of patients with autoimmune inflammatory rheumatic diseases (…

[HTML][HTML] COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study

GE Fragoulis, VK Bournia, E Mavrea… - Rheumatology …, 2022 - Springer
Objective To describe the rate and type of adverse effects (AEs) and the frequency of disease
flares after COVID-19 vaccination and to assess the reasons for vaccination hesitancy (non…

Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases

…, E Sfendouraki, S Panopoulos, V Bournia… - Arthritis Care & …, 2014 - Wiley Online Library
Objective Accurate diagnosis of cardiovascular involvement in connective tissue diseases (CTDs)
remains challenging. We hypothesized that cardiovascular magnetic resonance (CMR…